What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Surgery
Jeffrey S. Hyams focuses on Internal medicine, Inflammatory bowel disease, Gastroenterology, Ulcerative colitis and Surgery.
As part of his studies on Internal medicine, Jeffrey S. Hyams frequently links adjacent subjects like Endocrinology.
Jeffrey S. Hyams has included themes like Hemophagocytic lymphohistiocytosis, Immunology and Bone remodeling in his Inflammatory bowel disease study.
His Gastroenterology research is multidisciplinary, incorporating perspectives in El Niño, Pediatrics, Pathology, Thiopurine methyltransferase and Gastrointestinal agent.
Many of his research projects under Ulcerative colitis are closely connected to Lactic acid with Lactic acid, tying the diverse disciplines of science together.
His Surgery research integrates issues from Adalimumab and Severity of illness.
His most cited work include:
- The Treatment-Naive Microbiome in New-Onset Crohn’s Disease (1586 citations)
- Childhood Functional Gastrointestinal Disorders: Child/Adolescent (1304 citations)
- Development and validation of a pediatric Crohn's disease activity index. (781 citations)
What are the main themes of his work throughout his whole career to date?
Internal medicine, Gastroenterology, Ulcerative colitis, Crohn's disease and Inflammatory bowel disease are his primary areas of study.
The concepts of his Internal medicine study are interwoven with issues in Endocrinology and Surgery.
His Gastroenterology research includes themes of Pharmacokinetics, Crohn disease, El Niño, Pediatric ulcerative colitis and Calprotectin.
His Ulcerative colitis study combines topics from a wide range of disciplines, such as Prospective cohort study, Severity of illness, Colitis and Cohort.
His study looks at the intersection of Crohn's disease and topics like Pediatrics with Abdominal pain.
His research on Inflammatory bowel disease frequently connects to adjacent areas such as Immunology.
He most often published in these fields:
- Internal medicine (55.93%)
- Gastroenterology (35.97%)
- Ulcerative colitis (23.73%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (55.93%)
- Gastroenterology (35.97%)
- Crohn's disease (22.41%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Gastroenterology, Crohn's disease, Ulcerative colitis and Inflammatory bowel disease.
His research related to Disease, Infliximab, Pediatric ulcerative colitis, Pediatric Crohn's disease and Cohort might be considered part of Internal medicine.
His Gastroenterology research includes elements of Area under the curve, Pharmacokinetics, Feces and Calprotectin.
The Crohn's disease study combines topics in areas such as Adalimumab, Ustekinumab, Newly diagnosed, Pediatrics and C-reactive protein.
His work focuses on many connections between Ulcerative colitis and other disciplines, such as Colitis, that overlap with his field of interest in Cancer research.
His Inflammatory bowel disease study combines topics in areas such as Single-nucleotide polymorphism and Immunology.
Between 2017 and 2021, his most popular works were:
- Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy. (138 citations)
- Prevalence of Pediatric Functional Gastrointestinal Disorders Utilizing the Rome IV Criteria. (73 citations)
- Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response (61 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Surgery
Jeffrey S. Hyams mainly investigates Internal medicine, Disease, Crohn's disease, Inflammatory bowel disease and Ulcerative colitis.
His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Serology.
His work on Pediatric Crohn's disease as part of general Disease research is frequently linked to Proteomics methods, bridging the gap between disciplines.
His Crohn's disease research is multidisciplinary, relying on both Inflammation, Adalimumab, Histone methylation and Epigenetic Profile.
His research integrates issues of Genome-wide association study, Immunology, STAT5, Biomarker and C-reactive protein in his study of Inflammatory bowel disease.
Jeffrey S. Hyams combines subjects such as Irritable bowel syndrome, Severity of illness, Colitis and Prospective cohort study with his study of Ulcerative colitis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
